|By Marketwired .||
|June 30, 2014 04:13 PM EDT||
NEW YORK, NY -- (Marketwired) -- 06/30/14 -- Levi & Korsinsky announces that a class action lawsuit has been commenced in the United States District Court for the Southern District of Indiana on behalf of investors who purchased Endocyte, Inc. ("Endocyte" or the "Company") (NASDAQ: ECYT) common stock between March 21, 2014 and May 2, 2014.
For more information, click here: http://zlk.9nl.com/endocyte-ecyt.
The complaint alleges that throughout the Class Period defendants issued misleading statements regarding the efficacy of the Company's experimental drug VYNFINIT, and misrepresented and/or failed to disclose material information regarding the Company's business and financial prospects. In particular it is alleged that Endocyte misrepresented the nature of positive statements made about the drug in a March 21 press release, ultimately capitalizing on the resulting stock price increase to issue a public offering and sell shares at an inflated price.
If you suffered a loss in Endocyte you have until August 25, 2014 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. To obtain additional information, contact Joseph E. Levi, Esq. either via email at [email protected] or by telephone at (212) 363-7500, toll-free: (877) 363-5972, or visit http://zlk.9nl.com/endocyte-ecyt.
Levi & Korsinsky is a national firm with offices in New York, New Jersey, Connecticut and Washington D.C. The firm's 26 attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits. For more information, please feel free to contact any of the attorneys listed below. Attorney advertising. Prior results do not guarantee similar outcomes.
Levi & Korsinsky, LLP
Joseph Levi, Esq.
Eduard Korsinsky, Esq.
30 Broad Street - 24th Floor
New York, NY 10004
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (866) 367-6510
Ask someone to architect an Internet of Things (IoT) solution and you are guaranteed to see a reference to the cloud. This would lead you to believe that IoT requires the cloud to exist. However, there are many IoT use cases where the cloud is not feasible or desirable. In his session at @ThingsExpo, Dave McCarthy, Director of Products at Bsquare Corporation, will discuss the strategies that exist to extend intelligence directly to IoT devices and sensors, freeing them from the constraints of ...
Oct. 1, 2016 11:45 AM EDT Reads: 2,791
Oct. 1, 2016 11:30 AM EDT Reads: 1,322
Oct. 1, 2016 11:15 AM EDT Reads: 871
Oct. 1, 2016 10:45 AM EDT Reads: 605
Oct. 1, 2016 10:30 AM EDT Reads: 710
Oct. 1, 2016 10:30 AM EDT Reads: 1,724
Oct. 1, 2016 10:00 AM EDT Reads: 3,198
Oct. 1, 2016 10:00 AM EDT Reads: 606
Oct. 1, 2016 10:00 AM EDT Reads: 4,672
Oct. 1, 2016 10:00 AM EDT Reads: 519
Oct. 1, 2016 10:00 AM EDT Reads: 3,321
Oct. 1, 2016 09:45 AM EDT Reads: 2,769
Oct. 1, 2016 09:45 AM EDT Reads: 835
Oct. 1, 2016 09:15 AM EDT Reads: 1,677